Managing myelofibrosis in the frailty era: the expanding role of JAK inhibitors.
Saved in:
| Title: | Managing myelofibrosis in the frailty era: the expanding role of JAK inhibitors. |
|---|---|
| Authors: | De Fazio L; Department of Hematology-Oncology, Azienda Ospedaliera Renato Dulbecco, Catanzaro, Italy., Molica M; Department of Hematology-Oncology, Azienda Ospedaliera Renato Dulbecco, Catanzaro, Italy., Simio C; Department of Hematology-Oncology, Azienda Ospedaliera Renato Dulbecco, Catanzaro, Italy., Rossi M; Department of Hematology-Oncology, Azienda Ospedaliera Renato Dulbecco, Catanzaro, Italy. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2026 May; Vol. 67 (6), pp. 1257-1267. Date of Electronic Publication: 2026 Apr 14. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
